Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
Hematologic Malignancies (General / Unspecified)
-
-
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
-
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
-
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
-
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
Categories
Alliance Committee
Browse by Year